GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuraxis Inc (AMEX:NRXS) » Definitions » Days Inventory

Neuraxis (Neuraxis) Days Inventory : 24.94 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neuraxis Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Neuraxis's Average Total Inventories for the three months ended in Mar. 2024 was $0.02 Mil. Neuraxis's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.08 Mil. Hence, Neuraxis's Days Inventory for the three months ended in Mar. 2024 was 24.94.

The historical rank and industry rank for Neuraxis's Days Inventory or its related term are showing as below:

NRXS' s Days Inventory Range Over the Past 10 Years
Min: 41.56   Med: 55.26   Max: 81.2
Current: 51

During the past 4 years, Neuraxis's highest Days Inventory was 81.20. The lowest was 41.56. And the median was 55.26.

NRXS's Days Inventory is ranked better than
87.16% of 654 companies
in the Biotechnology industry
Industry Median: 192.63 vs NRXS: 51.00

Neuraxis's Days Inventory declined from Mar. 2023 (59.41) to Mar. 2024 (24.94).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Neuraxis's Inventory Turnover for the three months ended in Mar. 2024 was 3.66.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Neuraxis's Inventory-to-Revenue for the three months ended in Mar. 2024 was 0.03.


Neuraxis Days Inventory Historical Data

The historical data trend for Neuraxis's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuraxis Days Inventory Chart

Neuraxis Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Days Inventory
81.20 57.06 53.46 41.56

Neuraxis Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.41 81.19 53.80 35.49 24.94

Competitive Comparison of Neuraxis's Days Inventory

For the Biotechnology subindustry, Neuraxis's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuraxis's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuraxis's Days Inventory distribution charts can be found below:

* The bar in red indicates where Neuraxis's Days Inventory falls into.



Neuraxis Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Neuraxis's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0.048 + 0.021) / 2 ) / 0.303*365
=0.0345 / 0.303*365
=41.56

Neuraxis's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

Days Inventory (Q: Mar. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (0.021 + 0.02) / 2 ) / 0.075*365 / 4
=0.0205 / 0.075*365 / 4
=24.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuraxis  (AMEX:NRXS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Neuraxis's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Neuraxis's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Neuraxis Days Inventory Related Terms

Thank you for viewing the detailed overview of Neuraxis's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuraxis (Neuraxis) Business Description

Traded in Other Exchanges
N/A
Address
11550 N. Meridian Street, Suite 325, Carmel, IN, USA
Neuraxis Inc is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology.
Executives
Masimo Corp 10 percent owner 52 DISCOVERY, IRVINE CA 92618
John G Seale officer: CHIEF FINANCIAL OFFICER 10038 OXFORD PIKE, BROOKVILLE IN 47012
Brian Allen Carrico director, officer: CEO, DIRECTOR 11550 NORTH MERIDIAN STREET, SUITE 325, CARMEL IN 46032
Christopher Robin Brown director, officer: DIRECTOR OF INNOVATION 829 S. ADAMS ST, VERSAILLES IN 47042
Daniel Jerome Clarence officer: CHIEF OPERATING OFFICER 10461 W GRANDVIEW DRIVE, COLUMBUS IN 47201
Thomas Joeseph Carrico officer: CHIEF REGULATORY OFFICER 829 S. ADAMS ST., VERSAILLES IN 47042
Gary Merril Peterson officer: DIR.OF DESIGN & ENGINEERING 829 S. ADAMS ST., VERSAILLES IN 47042
Bradley Mitchell Watkins director 10322 MEDICIS PLACE, WELLINGTON FL 33449
Jane Elizabeth Keyser director 220 VIRGINIA AVENUE, INDIANAPOLIS IN 46204
Timothy Robert Henrichs director 324 LEITCH AVENUE, LA GRANGE IL 60525
Adrian Miranda officer: Chief Medical Officer, SVP 829 S. ADAMS STREET, VERSAILLES IN 47042